14.64
0.15 (1.04%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bullish | Bearish |
Medical Devices (Global) | Bullish | Bearish | |
Stock | Orthofix Medical Inc. | Bullish | Bearish |
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Value |
Ownership
Name | Date | Shares Held |
---|---|---|
Glenview Capital Management, Llc | 31 Dec 2023 | 500,000 |
Boone Capital Management Llc | 31 Dec 2023 | 500,000 |
52 Weeks Range |
9.57 - 21.60
|
|
High | 20.00 (Roth MKM, 36.61%) | Buy |
Median | 20.00 (36.61%) | |
Average | 20.00 (36.61%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Roth MKM | 08 May 2024 | 20.00 (36.61%) | Buy | 14.90 |
07 Mar 2024 | 15.00 (2.46%) | Hold | 14.34 |
No data within this time range.
Date | Type | Details |
---|---|---|
16 May 2024 | Announcement | Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program |
09 May 2024 | Announcement | Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail |
07 May 2024 | Announcement | Orthofix Reports First Quarter 2024 Results |
23 Apr 2024 | Announcement | Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 |
16 Apr 2024 | Announcement | Orthofix Names Andres Cedron as New Chief Legal Officer |
18 Mar 2024 | Announcement | Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer |
05 Mar 2024 | Announcement | Orthofix Reports Fourth Quarter and Full Year 2023 Results |
29 Feb 2024 | Announcement | Orthofix Announces New President for Bone Growth Therapies Business |
21 Feb 2024 | Announcement | Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |